What Will the Presidential Election Results Bode for the Cancer Moonshot?


The Cancer Moonshot may not be gone forever after the presidential election, but how it will continue is still being discussed.

What will happen to the Cancer Moonshot initiative after the White House shifts hands in January after the Nov. 8 election?

In short, it will continue, though experts are not quite sure how.

"The vice president has committed to this as his life's work, whether that takes place within the government or outside of the government, he is going to continue this work,” said Anabella Aspiras, director for patient engagement for the Moonshot initiative, at the 33rd Annual National Oncology Conference of the Association of Community Cancer Centers in October.

Republican nominee Donald Trump has remained quiet on the issue, while Hillary Clinton, the Democratic nominee, vowed to support Moonshot if she is elected.

The Cancer Moonshot was started in January of 2016 and is led by U.S. Vice President Joe Biden, whose son, Beau, a former Attorney General in Delaware, died of brain cancer in May 2015. The goal of the initiative is to “end cancer as we know it and achieve a decade worth of progress in five years,” said Aspiras.

As President Barack Obama’s presidency is coming to an end, advancements from Moonshot are continuing — seemingly full speed ahead.

In Biden’s Moonshot Report, which he delivered to the President and American people on Oct. 17 from the oval office, the vice president announced a number of private and public commitments to further the project.

For example, the National Cancer Institute, Amazon Web Services and Microsoft announced a collaboration that will build a model for maintaining cancer genomic data in the cloud, which will be available to researchers through the NCI’s Genomic Data Commons and Cancer Genomic cloud programs. The Department of Defense also launched a new study to help understand the biologic mechanisms of cancer.

On the private front, car share programs like Lyft and Uber expanded their support of affordable transportation for patients who may otherwise miss their appointments.

Overall, there were 70 commitments made this year for the Cancer Moonshot.

"The short answer is that cancer Moonshot will 100 percent continue. It will continue under the leadership and passion of Vice President Biden,” Aspiras said. "Its particular form within the government: we're just going to have to wait until the other side of Nov. 8.”

Related Videos
Image of a woman with dark brown hair and round glasses wearing pearl earrings.
A man with a dark gray button-up shirt with glasses and cropped brown hair.
Woman with dark brown hair and pink lipstick wearing a light pink blouse with a light brown blazer. Patients should have conversations with their providers about treatments after receiving diagnoses.
Man in a navy suit with a purple tie. Dr. Saby George talks to CURE about how treatment with Opdivo could mitigate disparities in patients with kidney cancer.
Dr. Andrea Apolo in an interview with CURE
Dr. Kim in an interview with CURE